{"entities": [{"EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "TradingSymbol": "ALNY", "EntityCentralIndexKey": "1178670", "db": 1, "Industry_SEC": "Pharmaceutical Preparations", "Industry_SEC_db": 2834, "Industry": "Pharmaceutical", "Industry_db": 37, "Region": "Massachusetts", "Region_db": 22, "SecurityExchangeName": "0", "SECurl": "0", "URL": "", "SEC_Update": "2021-11-11", "SEC_UpdateDateAndTime": null, "SecuritiesUpdate": null, "OpinionLastYear": null, "OpinionSecondLastYear": null, "OpinionThirdLastYear": null, "OpinionFourthLastYear": null, "ClockLastYear": 6.0, "ClockSecondLastYear": null, "ClockThirdLastYear": null, "ClockFourthLastYear": 0.0, "BridgeLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "BridgeSecondLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "BridgeThirdLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "BridgeFourthLastYear": "There are still some unexplained differences in the financial statements and it might not be exempt from material misstatements.", "Anomalies": "0", "AnomaliesRatio1": 31.52, "AnomaliesRatio2": 27.28, "AnomaliesRatio3": 16.77, "AnomaliesRatio4": 11.87, "AnomaliesRatio5": 10.81, "AnomaliesRatio6": 6.08, "NumberOfYearsAudited": 0, "CommonSharesIntrinsicValueLastYear": 1016247000, "CommonSharesIntrinsicValueSecondLastYear": null, "CommonSharesIntrinsicValueThirdLastYear": null, "CommonSharesIntrinsicValueFourthLastYear": null, "MarketCapitalizationLastYear": 16713738414, "MarketCapitalizationSecondLastYear": 12966295134, "MarketCapitalizationThirdLastYear": 7747289008, "MarketCapitalizationFourthLastYear": 12688206531, "CommonShareIntrinsicValueLastYear": 8.69, "CommonShareIntrinsicValueSecondLastYear": null, "CommonShareIntrinsicValueThirdLastYear": null, "CommonShareIntrinsicValueFourthLastYear": null, "CommonSharePriceLastYear": 142.85, "CommonSharePriceSecondLastYear": 115.17, "CommonSharePriceThirdLastYear": 72.91, "CommonSharePriceFourthLastYear": 127.05, "CommonSharesOutstandingLastYear": 117002019, "CommonSharesOutstandingSecondLastYear": 112583964, "CommonSharesOutstandingThirdLastYear": 106258250, "CommonSharesOutstandingFourthLastYear": 99867820, "month_end": 12, "lastyear": "2020-12-31", "secondlastyear": "2019-12-31", "thirdlastyear": "2018-12-31", "fourthlastyear": "2017-12-31", "fifthlastyear": "2016-12-31", "sixthlastyear": "2015-12-31", "amendlastyear": "", "amendsecondlastyear": "", "amendthirdlastyear": "", "amendfourthlastyear": "", "amendfifthlastyear": "", "amendsixthlastyear": "", "accessionnumberlastyear": "0001178670-21-000010", "accessionnumbersecondlastyear": "0001178670-20-000004", "accessionnumberthirdlastyear": "0001564590-19-003022", "accessionnumberfourthlastyear": "0001564590-18-002152", "accessionnumberfifthlastyear": "0001564590-17-001649", "accessionnumbersixthlastyear": "0001193125-16-462538", "urlbalancesheetlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000117867021000010/R2.htm", "urlbalancesheetsecondlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000117867020000004/R2.htm", "urlbalancesheetthirdlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000156459019003022/R2.htm", "urlbalancesheetfourthlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000156459018002152/R2.htm", "urlbalancesheetfifthlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000156459017001649/R2.htm", "urlbalancesheetsixthlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000119312516462538/R2.htm", "urlincomestatementlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000117867021000010/R4.htm", "urlincomestatementsecondlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000117867020000004/R4.htm", "urlincomestatementthirdlastyear": "", "urlincomestatementfourthlastyear": "", "urlincomestatementfifthlastyear": "", "urlincomestatementsixthlastyear": "", "urlcomprehensiveincomelastyear": "", "urlcomprehensiveincomesecondlastyear": "", "urlcomprehensiveincomethirdlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000156459019003022/R4.htm", "urlcomprehensiveincomefourthlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000156459018002152/R4.htm", "urlcomprehensiveincomefifthlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000156459017001649/R4.htm", "urlcomprehensiveincomesixthlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000119312516462538/R4.htm", "urlshareholdersequitylastyear": "", "urlshareholdersequitysecondlastyear": "", "urlshareholdersequitythirdlastyear": "", "urlshareholdersequityfourthlastyear": "", "urlshareholdersequityfifthlastyear": "", "urlshareholdersequitysixthlastyear": "", "urlcashflowlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000117867021000010/R6.htm", "urlcashflowsecondlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000117867020000004/R6.htm", "urlcashflowthirdlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000156459019003022/R7.htm", "urlcashflowfourthlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000156459018002152/R7.htm", "urlcashflowfifthlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000156459017001649/R7.htm", "urlcashflowsixthlastyear": "https://www.sec.gov/Archives/edgar/data/1178670/000119312516462538/R7.htm", "ad1.db": 0, "ad1.AccessionNumber": "0001178670-21-000010", "ad1.AmendmentFlag": "", "ad1.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "ad1.Period": "lastyear", "ad1.PeriodEndDate": "2020-12-31", "ad1.TradingSymbol": "ALNY", "ad1.CurrentAssets": 2614777000, "ad1.NonCurrentAssets": 792284000, "ad1.Assets": 0, "ad1.CurrentLiabilities": -585270000, "ad1.NonCurrentLiabilities": -1818860000, "ad1.Liabilities": 0, "ad1.ShareholdersEquity": -1002931000, "ad1.LiabilitiesAndShareholdersEquity": 0, "ad1.CurrentAssetsGL_i": "", "ad1.CurrentAssetsGL_ii": "", "ad1.CurrentAssetsGL_iii": "", "ad1.AnomalyCurrentAssets": 0, "ad1.AnomalyCurrentAssetsSEC": 0, "ad1.NonCurrentAssetsGL_i": "", "ad1.NonCurrentAssetsGL_ii": "", "ad1.NonCurrentAssetsGL_iii": "", "ad1.AnomalyNonCurrentAssets": 0, "ad1.AnomalyNonCurrentAssetsSEC": 0, "ad1.AnomalyAssets": 0, "ad1.CurrentLiabilitiesGL_i": "", "ad1.CurrentLiabilitiesGL_ii": "", "ad1.CurrentLiabilitiesGL_iii": "", "ad1.AnomalyCurrentLiabilities": -13316000, "ad1.AnomalyCurrentLiabilitiesSEC": 0, "ad1.NonCurrentLiabilitiesGL_i": "", "ad1.NonCurrentLiabilitiesGL_ii": "", "ad1.NonCurrentLiabilitiesGL_iii": "", "ad1.AnomalyNonCurrentLiabilities": -1071541000, "ad1.AnomalyNonCurrentLiabilitiesSEC": 0, "ad1.AnomalyLiabilities": 0, "ad1.AnomalyShareholdersEquity": -13316000, "ad1.ShareholdersEquityBalanceGL_i": "", "ad1.ShareholdersEquityBalanceGL_ii": "", "ad1.ShareholdersEquityBalanceGL_iii": "", "ad1.AnomalyShareholdersEquitySEC": 0, "ad1.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad1.Sales": 0, "ad1.CostOfSales": 0, "ad1.GrossMargin": -283468000, "ad1.OperatingExpenses": 0, "ad1.OperatingIncome": 828438000, "ad1.IncomeBeforeTaxes": 855600000, "ad1.NetIncome": 858281000, "ad1.NetIncomeAttributableToNonControllingInterest": 0, "ad1.GrossMarginGL_i": "", "ad1.GrossMarginGL_ii": "", "ad1.GrossMarginGL_iii": "", "ad1.AnomalyGrossMargin": 0, "ad1.OperatingExpensesGL_i": "", "ad1.OperatingExpensesGL_ii": "", "ad1.OperatingExpensesGL_iii": "", "ad1.AnomalyOperatingExpenses": 0, "ad1.OperatingIncomeGL_i": "", "ad1.OperatingIncomeGL_ii": "", "ad1.OperatingIncomeGL_iii": "", "ad1.AnomalyOperatingIncome": 0, "ad1.IncomeBeforeTaxesGL_i": "", "ad1.IncomeBeforeTaxesGL_ii": "", "ad1.IncomeBeforeTaxesGL_iii": "", "ad1.AnomalyIncomeBeforeTaxes": 0, "ad1.NetIncomeGL_i": "", "ad1.NetIncomeGL_ii": "", "ad1.NetIncomeGL_iii": "", "ad1.AnomalyNetIncome": 0, "ad1.OtherComprehensiveIncome": 7104000, "ad1.ComprehensiveIncome": 0, "ad1.OtherComprehensiveIncomeGL_i": "", "ad1.OtherComprehensiveIncomeGL_ii": "", "ad1.OtherComprehensiveIncomeGL_iii": "", "ad1.AnomalyOtherComprehensiveIncome": 858281000, "ad1.AnomalyComprehensiveIncome": 0, "ad1.ShareholdersEquityBeginning": 0, "ad1.ConvertibleDebt": 0, "ad1.CommonShares": 0, "ad1.PreferredShares": 0, "ad1.RetainedEarnings": 0, "ad1.AccumulatedOtherComprehensiveIncome": 0, "ad1.TreasuryShares": 0, "ad1.EmployeeBenefitTrust": 0, "ad1.NonControllingInterests": 0, "ad1.AnomalyConvertibleDebt": 0, "ad1.AnomalyCommonShares": -440118000, "ad1.AnomalyPreferredShares": 0, "ad1.AnomalyRetainedEarnings": 0, "ad1.AnomalyAccumulatedOtherComprehensiveIncome": -865385000, "ad1.AnomalyTreasuryShares": 0, "ad1.AnomalyEmployeeBenefitTrust": 0, "ad1.AnomalyNonControllingInterests": 0, "ad1.ShareholdersEquityGL_i": "", "ad1.ShareholdersEquityGL_ii": "", "ad1.ShareholdersEquityGL_iii": "", "ad1.OperatingActivities": 0, "ad1.InvestingActivities": 0, "ad1.FinancingActivities": 0, "ad1.IncreaseDecreaseInCash": 0, "ad1.CashFlowCashExplainedDifference": 2466000, "ad1.OperatingActivitiesGL_i": "", "ad1.OperatingActivitiesGL_ii": "", "ad1.OperatingActivitiesGL_iii": "", "ad1.AnomalyOperatingActivities": 0, "ad1.AnomalyOperatingActivitiesSEC": 0, "ad1.InvestingActivitiesGL_i": "", "ad1.InvestingActivitiesGL_ii": "", "ad1.InvestingActivitiesGL_iii": "", "ad1.AnomalyInvestingActivities": 0, "ad1.AnomalyInvestingActivitiesSEC": 0, "ad1.FinancingActivitiesGL_i": "", "ad1.FinancingActivitiesGL_ii": "", "ad1.FinancingActivitiesGL_iii": "", "ad1.AnomalyFinancingActivities": -508400000, "ad1.AnomalyFinancingActivitiesSEC": 0, "ad1.TargetWorkingCapital": 1.2, "ad1.ReinvestmentOfMaintenance": 70361000, "ad1.NormalizedDividendPaymentToNonControllingInterests": 0, "ad1.NormalizedDividendPaymentToPreferredShareholders": 0, "ad1.TheoricalInterestRate": 0.035, "ad1.TheoricalTaxRate": 0.15, "ad1.CapitalizationRateFloor": 0.021, "ad2.db": 20, "ad2.AccessionNumber": "0001178670-20-000004", "ad2.AmendmentFlag": "", "ad2.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "ad2.Period": "secondlastyear", "ad2.PeriodEndDate": "2019-12-31", "ad2.TradingSymbol": "ALNY", "ad2.CurrentAssets": 1715864000, "ad2.NonCurrentAssets": 679270000, "ad2.Assets": 0, "ad2.CurrentLiabilities": -352594000, "ad2.NonCurrentLiabilities": -603848000, "ad2.Liabilities": 0, "ad2.ShareholdersEquity": -1438692000, "ad2.LiabilitiesAndShareholdersEquity": 0, "ad2.CurrentAssetsGL_i": "", "ad2.CurrentAssetsGL_ii": "", "ad2.CurrentAssetsGL_iii": "", "ad2.AnomalyCurrentAssets": 0, "ad2.AnomalyCurrentAssetsSEC": 0, "ad2.NonCurrentAssetsGL_i": "", "ad2.NonCurrentAssetsGL_ii": "", "ad2.NonCurrentAssetsGL_iii": "", "ad2.AnomalyNonCurrentAssets": 0, "ad2.AnomalyNonCurrentAssetsSEC": 0, "ad2.AnomalyAssets": 0, "ad2.CurrentLiabilitiesGL_i": "", "ad2.CurrentLiabilitiesGL_ii": "", "ad2.CurrentLiabilitiesGL_iii": "", "ad2.AnomalyCurrentLiabilities": 0, "ad2.AnomalyCurrentLiabilitiesSEC": 0, "ad2.NonCurrentLiabilitiesGL_i": "", "ad2.NonCurrentLiabilitiesGL_ii": "", "ad2.NonCurrentLiabilitiesGL_iii": "", "ad2.AnomalyNonCurrentLiabilities": 0, "ad2.AnomalyNonCurrentLiabilitiesSEC": 0, "ad2.AnomalyLiabilities": 0, "ad2.AnomalyShareholdersEquity": 0, "ad2.ShareholdersEquityBalanceGL_i": "", "ad2.ShareholdersEquityBalanceGL_ii": "", "ad2.ShareholdersEquityBalanceGL_iii": "", "ad2.AnomalyShareholdersEquitySEC": 0, "ad2.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad2.Sales": 0, "ad2.CostOfSales": 0, "ad2.GrossMargin": -141475000, "ad2.OperatingExpenses": 0, "ad2.OperatingIncome": 939431000, "ad2.IncomeBeforeTaxes": 885253000, "ad2.NetIncome": 886116000, "ad2.NetIncomeAttributableToNonControllingInterest": 0, "ad2.GrossMarginGL_i": "", "ad2.GrossMarginGL_ii": "", "ad2.GrossMarginGL_iii": "", "ad2.AnomalyGrossMargin": 0, "ad2.OperatingExpensesGL_i": "", "ad2.OperatingExpensesGL_ii": "", "ad2.OperatingExpensesGL_iii": "", "ad2.AnomalyOperatingExpenses": 0, "ad2.OperatingIncomeGL_i": "", "ad2.OperatingIncomeGL_ii": "", "ad2.OperatingIncomeGL_iii": "", "ad2.AnomalyOperatingIncome": 0, "ad2.IncomeBeforeTaxesGL_i": "", "ad2.IncomeBeforeTaxesGL_ii": "", "ad2.IncomeBeforeTaxesGL_iii": "", "ad2.AnomalyIncomeBeforeTaxes": 0, "ad2.NetIncomeGL_i": "", "ad2.NetIncomeGL_ii": "", "ad2.NetIncomeGL_iii": "", "ad2.AnomalyNetIncome": 0, "ad2.OtherComprehensiveIncome": 3305000, "ad2.ComprehensiveIncome": 0, "ad2.OtherComprehensiveIncomeGL_i": "", "ad2.OtherComprehensiveIncomeGL_ii": "", "ad2.OtherComprehensiveIncomeGL_iii": "", "ad2.AnomalyOtherComprehensiveIncome": 886116000, "ad2.AnomalyComprehensiveIncome": 0, "ad2.ShareholdersEquityBeginning": 0, "ad2.ConvertibleDebt": 0, "ad2.CommonShares": 0, "ad2.PreferredShares": 0, "ad2.RetainedEarnings": 0, "ad2.AccumulatedOtherComprehensiveIncome": 0, "ad2.TreasuryShares": 0, "ad2.EmployeeBenefitTrust": 0, "ad2.NonControllingInterests": 0, "ad2.AnomalyConvertibleDebt": 0, "ad2.AnomalyCommonShares": 240729000, "ad2.AnomalyPreferredShares": 0, "ad2.AnomalyRetainedEarnings": 0, "ad2.AnomalyAccumulatedOtherComprehensiveIncome": -889421000, "ad2.AnomalyTreasuryShares": 0, "ad2.AnomalyEmployeeBenefitTrust": 0, "ad2.AnomalyNonControllingInterests": 0, "ad2.ShareholdersEquityGL_i": "", "ad2.ShareholdersEquityGL_ii": "", "ad2.ShareholdersEquityGL_iii": "", "ad2.OperatingActivities": 0, "ad2.InvestingActivities": 0, "ad2.FinancingActivities": 0, "ad2.IncreaseDecreaseInCash": 0, "ad2.CashFlowCashExplainedDifference": 2450000, "ad2.OperatingActivitiesGL_i": "", "ad2.OperatingActivitiesGL_ii": "", "ad2.OperatingActivitiesGL_iii": "", "ad2.AnomalyOperatingActivities": 0, "ad2.AnomalyOperatingActivitiesSEC": 0, "ad2.InvestingActivitiesGL_i": "", "ad2.InvestingActivitiesGL_ii": "", "ad2.InvestingActivitiesGL_iii": "", "ad2.AnomalyInvestingActivities": 0, "ad2.AnomalyInvestingActivitiesSEC": 0, "ad2.FinancingActivitiesGL_i": "", "ad2.FinancingActivitiesGL_ii": "", "ad2.FinancingActivitiesGL_iii": "", "ad2.AnomalyFinancingActivities": -381900000, "ad2.AnomalyFinancingActivitiesSEC": 0, "ad2.TargetWorkingCapital": 1.2, "ad2.ReinvestmentOfMaintenance": 140156000, "ad2.NormalizedDividendPaymentToNonControllingInterests": 0, "ad2.NormalizedDividendPaymentToPreferredShareholders": 0, "ad2.TheoricalInterestRate": 0.035, "ad2.TheoricalTaxRate": 0.15, "ad2.CapitalizationRateFloor": 0.021, "ad3.db": 0, "ad3.AccessionNumber": "0001564590-19-003022", "ad3.AmendmentFlag": "", "ad3.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "ad3.Period": "thirdlastyear", "ad3.PeriodEndDate": "2018-12-31", "ad3.TradingSymbol": "ALNY", "ad3.CurrentAssets": 1200696000, "ad3.NonCurrentAssets": 374106000, "ad3.Assets": 0, "ad3.CurrentLiabilities": -179494000, "ad3.NonCurrentLiabilities": -93343000, "ad3.Liabilities": 0, "ad3.ShareholdersEquity": -1301965000, "ad3.LiabilitiesAndShareholdersEquity": 0, "ad3.CurrentAssetsGL_i": "", "ad3.CurrentAssetsGL_ii": "", "ad3.CurrentAssetsGL_iii": "", "ad3.AnomalyCurrentAssets": 0, "ad3.AnomalyCurrentAssetsSEC": 0, "ad3.NonCurrentAssetsGL_i": "", "ad3.NonCurrentAssetsGL_ii": "", "ad3.NonCurrentAssetsGL_iii": "", "ad3.AnomalyNonCurrentAssets": 0, "ad3.AnomalyNonCurrentAssetsSEC": 0, "ad3.AnomalyAssets": 0, "ad3.CurrentLiabilitiesGL_i": "", "ad3.CurrentLiabilitiesGL_ii": "", "ad3.CurrentLiabilitiesGL_iii": "", "ad3.AnomalyCurrentLiabilities": 0, "ad3.AnomalyCurrentLiabilitiesSEC": 0, "ad3.NonCurrentLiabilitiesGL_i": "", "ad3.NonCurrentLiabilitiesGL_ii": "", "ad3.NonCurrentLiabilitiesGL_iii": "", "ad3.AnomalyNonCurrentLiabilities": 0, "ad3.AnomalyNonCurrentLiabilitiesSEC": 0, "ad3.AnomalyLiabilities": 0, "ad3.AnomalyShareholdersEquity": 0, "ad3.ShareholdersEquityBalanceGL_i": "", "ad3.ShareholdersEquityBalanceGL_ii": "", "ad3.ShareholdersEquityBalanceGL_iii": "", "ad3.AnomalyShareholdersEquitySEC": 0, "ad3.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad3.Sales": 0, "ad3.CostOfSales": 0, "ad3.GrossMargin": 0, "ad3.OperatingExpenses": 0, "ad3.OperatingIncome": 0, "ad3.IncomeBeforeTaxes": 0, "ad3.NetIncome": 0, "ad3.NetIncomeAttributableToNonControllingInterest": 0, "ad3.GrossMarginGL_i": "", "ad3.GrossMarginGL_ii": "", "ad3.GrossMarginGL_iii": "", "ad3.AnomalyGrossMargin": 0, "ad3.OperatingExpensesGL_i": "", "ad3.OperatingExpensesGL_ii": "", "ad3.OperatingExpensesGL_iii": "", "ad3.AnomalyOperatingExpenses": 0, "ad3.OperatingIncomeGL_i": "", "ad3.OperatingIncomeGL_ii": "", "ad3.OperatingIncomeGL_iii": "", "ad3.AnomalyOperatingIncome": 0, "ad3.IncomeBeforeTaxesGL_i": "", "ad3.IncomeBeforeTaxesGL_ii": "", "ad3.IncomeBeforeTaxesGL_iii": "", "ad3.AnomalyIncomeBeforeTaxes": 0, "ad3.NetIncomeGL_i": "", "ad3.NetIncomeGL_ii": "", "ad3.NetIncomeGL_iii": "", "ad3.AnomalyNetIncome": 0, "ad3.OtherComprehensiveIncome": -1220000, "ad3.ComprehensiveIncome": 0, "ad3.OtherComprehensiveIncomeGL_i": "", "ad3.OtherComprehensiveIncomeGL_ii": "", "ad3.OtherComprehensiveIncomeGL_iii": "", "ad3.AnomalyOtherComprehensiveIncome": -1220000, "ad3.AnomalyComprehensiveIncome": 0, "ad3.ShareholdersEquityBeginning": 0, "ad3.ConvertibleDebt": 0, "ad3.CommonShares": 0, "ad3.PreferredShares": 0, "ad3.RetainedEarnings": 0, "ad3.AccumulatedOtherComprehensiveIncome": 0, "ad3.TreasuryShares": 0, "ad3.EmployeeBenefitTrust": 0, "ad3.NonControllingInterests": 0, "ad3.AnomalyConvertibleDebt": 0, "ad3.AnomalyCommonShares": 0, "ad3.AnomalyPreferredShares": 0, "ad3.AnomalyRetainedEarnings": -693287000, "ad3.AnomalyAccumulatedOtherComprehensiveIncome": 1220000, "ad3.AnomalyTreasuryShares": 0, "ad3.AnomalyEmployeeBenefitTrust": 0, "ad3.AnomalyNonControllingInterests": 0, "ad3.ShareholdersEquityGL_i": "", "ad3.ShareholdersEquityGL_ii": "", "ad3.ShareholdersEquityGL_iii": "", "ad3.OperatingActivities": 0, "ad3.InvestingActivities": 0, "ad3.FinancingActivities": 0, "ad3.IncreaseDecreaseInCash": 0, "ad3.CashFlowCashExplainedDifference": 2485000, "ad3.OperatingActivitiesGL_i": "", "ad3.OperatingActivitiesGL_ii": "", "ad3.OperatingActivitiesGL_iii": "", "ad3.AnomalyOperatingActivities": 0, "ad3.AnomalyOperatingActivitiesSEC": 0, "ad3.InvestingActivitiesGL_i": "", "ad3.InvestingActivitiesGL_ii": "", "ad3.InvestingActivitiesGL_iii": "", "ad3.AnomalyInvestingActivities": 0, "ad3.AnomalyInvestingActivitiesSEC": 0, "ad3.FinancingActivitiesGL_i": "", "ad3.FinancingActivitiesGL_ii": "", "ad3.FinancingActivitiesGL_iii": "", "ad3.AnomalyFinancingActivities": 0, "ad3.AnomalyFinancingActivitiesSEC": 0, "ad3.TargetWorkingCapital": 1.2, "ad3.ReinvestmentOfMaintenance": 126887000, "ad3.NormalizedDividendPaymentToNonControllingInterests": 0, "ad3.NormalizedDividendPaymentToPreferredShareholders": 0, "ad3.TheoricalInterestRate": 0.035, "ad3.TheoricalTaxRate": 0.0, "ad3.CapitalizationRateFloor": 0.021, "ad4.db": 0, "ad4.AccessionNumber": "0001564590-18-002152", "ad4.AmendmentFlag": "", "ad4.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "ad4.Period": "fourthlastyear", "ad4.PeriodEndDate": "2017-12-31", "ad4.TradingSymbol": "ALNY", "ad4.CurrentAssets": 1764740000, "ad4.NonCurrentAssets": 229990000, "ad4.Assets": 0, "ad4.CurrentLiabilities": -144251000, "ad4.NonCurrentLiabilities": -84048000, "ad4.Liabilities": 0, "ad4.ShareholdersEquity": -1766431000, "ad4.LiabilitiesAndShareholdersEquity": 0, "ad4.CurrentAssetsGL_i": "", "ad4.CurrentAssetsGL_ii": "", "ad4.CurrentAssetsGL_iii": "", "ad4.AnomalyCurrentAssets": 0, "ad4.AnomalyCurrentAssetsSEC": 0, "ad4.NonCurrentAssetsGL_i": "", "ad4.NonCurrentAssetsGL_ii": "", "ad4.NonCurrentAssetsGL_iii": "", "ad4.AnomalyNonCurrentAssets": 13919000, "ad4.AnomalyNonCurrentAssetsSEC": 0, "ad4.AnomalyAssets": 0, "ad4.CurrentLiabilitiesGL_i": "", "ad4.CurrentLiabilitiesGL_ii": "", "ad4.CurrentLiabilitiesGL_iii": "", "ad4.AnomalyCurrentLiabilities": 0, "ad4.AnomalyCurrentLiabilitiesSEC": 0, "ad4.NonCurrentLiabilitiesGL_i": "", "ad4.NonCurrentLiabilitiesGL_ii": "", "ad4.NonCurrentLiabilitiesGL_iii": "", "ad4.AnomalyNonCurrentLiabilities": 0, "ad4.AnomalyNonCurrentLiabilitiesSEC": 0, "ad4.AnomalyLiabilities": 0, "ad4.AnomalyShareholdersEquity": 0, "ad4.ShareholdersEquityBalanceGL_i": "", "ad4.ShareholdersEquityBalanceGL_ii": "", "ad4.ShareholdersEquityBalanceGL_iii": "", "ad4.AnomalyShareholdersEquitySEC": 0, "ad4.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad4.Sales": 0, "ad4.CostOfSales": 0, "ad4.GrossMargin": 0, "ad4.OperatingExpenses": 0, "ad4.OperatingIncome": 0, "ad4.IncomeBeforeTaxes": 0, "ad4.NetIncome": 0, "ad4.NetIncomeAttributableToNonControllingInterest": 0, "ad4.GrossMarginGL_i": "", "ad4.GrossMarginGL_ii": "", "ad4.GrossMarginGL_iii": "", "ad4.AnomalyGrossMargin": 0, "ad4.OperatingExpensesGL_i": "", "ad4.OperatingExpensesGL_ii": "", "ad4.OperatingExpensesGL_iii": "", "ad4.AnomalyOperatingExpenses": 0, "ad4.OperatingIncomeGL_i": "", "ad4.OperatingIncomeGL_ii": "", "ad4.OperatingIncomeGL_iii": "", "ad4.AnomalyOperatingIncome": 0, "ad4.IncomeBeforeTaxesGL_i": "", "ad4.IncomeBeforeTaxesGL_ii": "", "ad4.IncomeBeforeTaxesGL_iii": "", "ad4.AnomalyIncomeBeforeTaxes": 0, "ad4.NetIncomeGL_i": "", "ad4.NetIncomeGL_ii": "", "ad4.NetIncomeGL_iii": "", "ad4.AnomalyNetIncome": 0, "ad4.OtherComprehensiveIncome": 992000, "ad4.ComprehensiveIncome": 0, "ad4.OtherComprehensiveIncomeGL_i": "", "ad4.OtherComprehensiveIncomeGL_ii": "", "ad4.OtherComprehensiveIncomeGL_iii": "", "ad4.AnomalyOtherComprehensiveIncome": 992000, "ad4.AnomalyComprehensiveIncome": 0, "ad4.ShareholdersEquityBeginning": 0, "ad4.ConvertibleDebt": 0, "ad4.CommonShares": 0, "ad4.PreferredShares": 0, "ad4.RetainedEarnings": 0, "ad4.AccumulatedOtherComprehensiveIncome": 0, "ad4.TreasuryShares": 0, "ad4.EmployeeBenefitTrust": 0, "ad4.NonControllingInterests": 0, "ad4.AnomalyConvertibleDebt": 0, "ad4.AnomalyCommonShares": 0, "ad4.AnomalyPreferredShares": 0, "ad4.AnomalyRetainedEarnings": -490874000, "ad4.AnomalyAccumulatedOtherComprehensiveIncome": -992000, "ad4.AnomalyTreasuryShares": 0, "ad4.AnomalyEmployeeBenefitTrust": 0, "ad4.AnomalyNonControllingInterests": 0, "ad4.ShareholdersEquityGL_i": "", "ad4.ShareholdersEquityGL_ii": "", "ad4.ShareholdersEquityGL_iii": "", "ad4.OperatingActivities": 0, "ad4.InvestingActivities": 0, "ad4.FinancingActivities": 0, "ad4.IncreaseDecreaseInCash": 0, "ad4.CashFlowCashExplainedDifference": 0, "ad4.OperatingActivitiesGL_i": "", "ad4.OperatingActivitiesGL_ii": "", "ad4.OperatingActivitiesGL_iii": "", "ad4.AnomalyOperatingActivities": 0, "ad4.AnomalyOperatingActivitiesSEC": 0, "ad4.InvestingActivitiesGL_i": "", "ad4.InvestingActivitiesGL_ii": "", "ad4.InvestingActivitiesGL_iii": "", "ad4.AnomalyInvestingActivities": 0, "ad4.AnomalyInvestingActivitiesSEC": 0, "ad4.FinancingActivitiesGL_i": "", "ad4.FinancingActivitiesGL_ii": "", "ad4.FinancingActivitiesGL_iii": "", "ad4.AnomalyFinancingActivities": 0, "ad4.AnomalyFinancingActivitiesSEC": 0, "ad4.TargetWorkingCapital": 1.2, "ad4.ReinvestmentOfMaintenance": 104209000, "ad4.NormalizedDividendPaymentToNonControllingInterests": 0, "ad4.NormalizedDividendPaymentToPreferredShareholders": 0, "ad4.TheoricalInterestRate": 0.035, "ad4.TheoricalTaxRate": 0.0, "ad4.CapitalizationRateFloor": 0.021, "ad5.db": 0, "ad5.AccessionNumber": "0001564590-17-001649", "ad5.AmendmentFlag": "", "ad5.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "ad5.Period": "fifthlastyear", "ad5.PeriodEndDate": "2016-12-31", "ad5.TradingSymbol": "ALNY", "ad5.CurrentAssets": 671877000, "ad5.NonCurrentAssets": 590933000, "ad5.Assets": 0, "ad5.CurrentLiabilities": -131699000, "ad5.NonCurrentLiabilities": -210890000, "ad5.Liabilities": 0, "ad5.ShareholdersEquity": -920221000, "ad5.LiabilitiesAndShareholdersEquity": 0, "ad5.CurrentAssetsGL_i": "", "ad5.CurrentAssetsGL_ii": "", "ad5.CurrentAssetsGL_iii": "", "ad5.AnomalyCurrentAssets": 0, "ad5.AnomalyCurrentAssetsSEC": 0, "ad5.NonCurrentAssetsGL_i": "", "ad5.NonCurrentAssetsGL_ii": "", "ad5.NonCurrentAssetsGL_iii": "", "ad5.AnomalyNonCurrentAssets": 324799000, "ad5.AnomalyNonCurrentAssetsSEC": 0, "ad5.AnomalyAssets": 0, "ad5.CurrentLiabilitiesGL_i": "", "ad5.CurrentLiabilitiesGL_ii": "", "ad5.CurrentLiabilitiesGL_iii": "", "ad5.AnomalyCurrentLiabilities": 0, "ad5.AnomalyCurrentLiabilitiesSEC": 0, "ad5.NonCurrentLiabilitiesGL_i": "", "ad5.NonCurrentLiabilitiesGL_ii": "", "ad5.NonCurrentLiabilitiesGL_iii": "", "ad5.AnomalyNonCurrentLiabilities": 0, "ad5.AnomalyNonCurrentLiabilitiesSEC": 0, "ad5.AnomalyLiabilities": 0, "ad5.AnomalyShareholdersEquity": 0, "ad5.ShareholdersEquityBalanceGL_i": "", "ad5.ShareholdersEquityBalanceGL_ii": "", "ad5.ShareholdersEquityBalanceGL_iii": "", "ad5.AnomalyShareholdersEquitySEC": 0, "ad5.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad5.Sales": 0, "ad5.CostOfSales": 0, "ad5.GrossMargin": 0, "ad5.OperatingExpenses": 0, "ad5.OperatingIncome": 0, "ad5.IncomeBeforeTaxes": 0, "ad5.NetIncome": 0, "ad5.NetIncomeAttributableToNonControllingInterest": 0, "ad5.GrossMarginGL_i": "", "ad5.GrossMarginGL_ii": "", "ad5.GrossMarginGL_iii": "", "ad5.AnomalyGrossMargin": 0, "ad5.OperatingExpensesGL_i": "", "ad5.OperatingExpensesGL_ii": "", "ad5.OperatingExpensesGL_iii": "", "ad5.AnomalyOperatingExpenses": 0, "ad5.OperatingIncomeGL_i": "", "ad5.OperatingIncomeGL_ii": "", "ad5.OperatingIncomeGL_iii": "", "ad5.AnomalyOperatingIncome": 0, "ad5.IncomeBeforeTaxesGL_i": "", "ad5.IncomeBeforeTaxesGL_ii": "", "ad5.IncomeBeforeTaxesGL_iii": "", "ad5.AnomalyIncomeBeforeTaxes": 0, "ad5.NetIncomeGL_i": "", "ad5.NetIncomeGL_ii": "", "ad5.NetIncomeGL_iii": "", "ad5.AnomalyNetIncome": 0, "ad5.OtherComprehensiveIncome": 37810000, "ad5.ComprehensiveIncome": 0, "ad5.OtherComprehensiveIncomeGL_i": "", "ad5.OtherComprehensiveIncomeGL_ii": "", "ad5.OtherComprehensiveIncomeGL_iii": "", "ad5.AnomalyOtherComprehensiveIncome": 37810000, "ad5.AnomalyComprehensiveIncome": 0, "ad5.ShareholdersEquityBeginning": 0, "ad5.ConvertibleDebt": 0, "ad5.CommonShares": 0, "ad5.PreferredShares": 0, "ad5.RetainedEarnings": 0, "ad5.AccumulatedOtherComprehensiveIncome": 0, "ad5.TreasuryShares": 0, "ad5.EmployeeBenefitTrust": 0, "ad5.NonControllingInterests": 0, "ad5.AnomalyConvertibleDebt": 0, "ad5.AnomalyCommonShares": 0, "ad5.AnomalyPreferredShares": 0, "ad5.AnomalyRetainedEarnings": -410108000, "ad5.AnomalyAccumulatedOtherComprehensiveIncome": -37810000, "ad5.AnomalyTreasuryShares": 0, "ad5.AnomalyEmployeeBenefitTrust": 0, "ad5.AnomalyNonControllingInterests": 0, "ad5.ShareholdersEquityGL_i": "", "ad5.ShareholdersEquityGL_ii": "", "ad5.ShareholdersEquityGL_iii": "", "ad5.OperatingActivities": 0, "ad5.InvestingActivities": 0, "ad5.FinancingActivities": 0, "ad5.IncreaseDecreaseInCash": 0, "ad5.CashFlowCashExplainedDifference": 0, "ad5.OperatingActivitiesGL_i": "", "ad5.OperatingActivitiesGL_ii": "", "ad5.OperatingActivitiesGL_iii": "", "ad5.AnomalyOperatingActivities": 0, "ad5.AnomalyOperatingActivitiesSEC": 0, "ad5.InvestingActivitiesGL_i": "", "ad5.InvestingActivitiesGL_ii": "", "ad5.InvestingActivitiesGL_iii": "", "ad5.AnomalyInvestingActivities": 0, "ad5.AnomalyInvestingActivitiesSEC": 0, "ad5.FinancingActivitiesGL_i": "", "ad5.FinancingActivitiesGL_ii": "", "ad5.FinancingActivitiesGL_iii": "", "ad5.AnomalyFinancingActivities": 0, "ad5.AnomalyFinancingActivitiesSEC": 0, "ad5.TargetWorkingCapital": 1.2, "ad5.ReinvestmentOfMaintenance": 64557000, "ad5.NormalizedDividendPaymentToNonControllingInterests": 0, "ad5.NormalizedDividendPaymentToPreferredShareholders": 0, "ad5.TheoricalInterestRate": 0.035, "ad5.TheoricalTaxRate": 0.0, "ad5.CapitalizationRateFloor": 0.021, "ad6.db": 0, "ad6.AccessionNumber": "0001193125-16-462538", "ad6.AmendmentFlag": "", "ad6.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "ad6.Period": "sixthlastyear", "ad6.PeriodEndDate": "2015-12-31", "ad6.TradingSymbol": "ALNY", "ad6.CurrentAssets": 1105388000, "ad6.NonCurrentAssets": 281122000, "ad6.Assets": 0, "ad6.CurrentLiabilities": -62099000, "ad6.NonCurrentLiabilities": -59697000, "ad6.Liabilities": 0, "ad6.ShareholdersEquity": -1264714000, "ad6.LiabilitiesAndShareholdersEquity": 0, "ad6.CurrentAssetsGL_i": "", "ad6.CurrentAssetsGL_ii": "", "ad6.CurrentAssetsGL_iii": "", "ad6.AnomalyCurrentAssets": 0, "ad6.AnomalyCurrentAssetsSEC": 0, "ad6.NonCurrentAssetsGL_i": "", "ad6.NonCurrentAssetsGL_ii": "", "ad6.NonCurrentAssetsGL_iii": "", "ad6.AnomalyNonCurrentAssets": 251839000, "ad6.AnomalyNonCurrentAssetsSEC": 0, "ad6.AnomalyAssets": 0, "ad6.CurrentLiabilitiesGL_i": "", "ad6.CurrentLiabilitiesGL_ii": "", "ad6.CurrentLiabilitiesGL_iii": "", "ad6.AnomalyCurrentLiabilities": 0, "ad6.AnomalyCurrentLiabilitiesSEC": 0, "ad6.NonCurrentLiabilitiesGL_i": "", "ad6.NonCurrentLiabilitiesGL_ii": "", "ad6.NonCurrentLiabilitiesGL_iii": "", "ad6.AnomalyNonCurrentLiabilities": 0, "ad6.AnomalyNonCurrentLiabilitiesSEC": 0, "ad6.AnomalyLiabilities": 0, "ad6.AnomalyShareholdersEquity": 0, "ad6.ShareholdersEquityBalanceGL_i": "", "ad6.ShareholdersEquityBalanceGL_ii": "", "ad6.ShareholdersEquityBalanceGL_iii": "", "ad6.AnomalyShareholdersEquitySEC": 0, "ad6.AnomalyLiabilitiesAndShareholdersEquity": 0, "ad6.Sales": 0, "ad6.CostOfSales": 0, "ad6.GrossMargin": 0, "ad6.OperatingExpenses": 0, "ad6.OperatingIncome": 0, "ad6.IncomeBeforeTaxes": 0, "ad6.NetIncome": 0, "ad6.NetIncomeAttributableToNonControllingInterest": 0, "ad6.GrossMarginGL_i": "", "ad6.GrossMarginGL_ii": "", "ad6.GrossMarginGL_iii": "", "ad6.AnomalyGrossMargin": 0, "ad6.OperatingExpensesGL_i": "", "ad6.OperatingExpensesGL_ii": "", "ad6.OperatingExpensesGL_iii": "", "ad6.AnomalyOperatingExpenses": 0, "ad6.OperatingIncomeGL_i": "", "ad6.OperatingIncomeGL_ii": "", "ad6.OperatingIncomeGL_iii": "", "ad6.AnomalyOperatingIncome": 0, "ad6.IncomeBeforeTaxesGL_i": "", "ad6.IncomeBeforeTaxesGL_ii": "", "ad6.IncomeBeforeTaxesGL_iii": "", "ad6.AnomalyIncomeBeforeTaxes": 0, "ad6.NetIncomeGL_i": "", "ad6.NetIncomeGL_ii": "", "ad6.NetIncomeGL_iii": "", "ad6.AnomalyNetIncome": 0, "ad6.OtherComprehensiveIncome": 44394000, "ad6.ComprehensiveIncome": 0, "ad6.OtherComprehensiveIncomeGL_i": "", "ad6.OtherComprehensiveIncomeGL_ii": "", "ad6.OtherComprehensiveIncomeGL_iii": "", "ad6.AnomalyOtherComprehensiveIncome": 44394000, "ad6.AnomalyComprehensiveIncome": 0, "ad6.ShareholdersEquityBeginning": 0, "ad6.ConvertibleDebt": 0, "ad6.CommonShares": 0, "ad6.PreferredShares": 0, "ad6.RetainedEarnings": 0, "ad6.AccumulatedOtherComprehensiveIncome": 0, "ad6.TreasuryShares": 0, "ad6.EmployeeBenefitTrust": 0, "ad6.NonControllingInterests": 0, "ad6.AnomalyConvertibleDebt": 0, "ad6.AnomalyCommonShares": 0, "ad6.AnomalyPreferredShares": 0, "ad6.AnomalyRetainedEarnings": 0, "ad6.AnomalyAccumulatedOtherComprehensiveIncome": -44394000, "ad6.AnomalyTreasuryShares": 0, "ad6.AnomalyEmployeeBenefitTrust": 0, "ad6.AnomalyNonControllingInterests": 0, "ad6.ShareholdersEquityGL_i": "", "ad6.ShareholdersEquityGL_ii": "", "ad6.ShareholdersEquityGL_iii": "", "ad6.OperatingActivities": 0, "ad6.InvestingActivities": 0, "ad6.FinancingActivities": 0, "ad6.IncreaseDecreaseInCash": 0, "ad6.CashFlowCashExplainedDifference": 0, "ad6.OperatingActivitiesGL_i": "", "ad6.OperatingActivitiesGL_ii": "", "ad6.OperatingActivitiesGL_iii": "", "ad6.AnomalyOperatingActivities": 0, "ad6.AnomalyOperatingActivitiesSEC": 0, "ad6.InvestingActivitiesGL_i": "", "ad6.InvestingActivitiesGL_ii": "", "ad6.InvestingActivitiesGL_iii": "", "ad6.AnomalyInvestingActivities": 0, "ad6.AnomalyInvestingActivitiesSEC": 0, "ad6.FinancingActivitiesGL_i": "", "ad6.FinancingActivitiesGL_ii": "", "ad6.FinancingActivitiesGL_iii": "", "ad6.AnomalyFinancingActivities": 0, "ad6.AnomalyFinancingActivitiesSEC": 0, "ad6.TargetWorkingCapital": 1.2, "ad6.ReinvestmentOfMaintenance": 12950000, "ad6.NormalizedDividendPaymentToNonControllingInterests": 0, "ad6.NormalizedDividendPaymentToPreferredShareholders": 0, "ad6.TheoricalInterestRate": 0.035, "ad6.TheoricalTaxRate": 0.0, "ad6.CapitalizationRateFloor": 0.021, "cf1.AccessionNumber": "0001178670-21-000010", "cf1.AmendmentFlag": "", "cf1.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "cf1.Period": "lastyear", "cf1.PeriodEndDate": "2020-12-31", "cf1.TradingSymbol": "ALNY", "cf1.CashBeginningBalance": 549628000, "cf1.EffectOfExchangeRateOnCash": 4918000, "cf1.DepreciationDepletionAndAmortization": 74435000, "cf1.GainRelatedToDisposalOrSale": -54042000, "cf1.RestructuringAndOtherSpecialCharges": 0, "cf1.AccruedEmployeeCompensation": 0, "cf1.ShareBasedCompensation": 139873000, "cf1.IncreaseDecreaseInIncomeTaxExpenseBenefit": 0, "cf1.OtherNonCashIncomeExpense": 84496000, "cf1.IncreaseDecreaseInAccountsReceivable": -56236000, "cf1.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": 15230000, "cf1.IncreaseDecreaseInInventories": -35426000, "cf1.IncreaseDecreaseInOtherReceivables": 0, "cf1.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 143732000, "cf1.IncreaseDecreaseInContractWithCustomerLiability": -43965000, "cf1.IncreaseDecreaseInRetirementBenefits": 0, "cf1.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf1.IncreaseDecreaseOperatingLeaseCurrent": -41586000, "cf1.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf1.IncreaseDecreaseInOtherOperatingActivities": 16809000, "cf1.PaymentsToAcquireInvestments": -2051526000, "cf1.ProceedsOfInvestments": 1691669000, "cf1.PaymentsToAcquirePropertyPlantAndEquipment": -70361000, "cf1.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf1.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf1.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf1.ProceedsRelatedToInsuranceSettlement": 0, "cf1.ReveiptOfGovernmentGrants": 0, "cf1.PaymentOfLicenseFee": 0, "cf1.InvestingActivitiesInDiscontinuedOperations": 0, "cf1.OtherInvestingActivities": -5300000, "cf1.FinanceLeasePrincipalPayments": 0, "cf1.ProceedsFromIssuanceOfCommonShares": 299498000, "cf1.ProceedsFromSharePurchasePlanAndOptionsExercice": 200484000, "cf1.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf1.PaymentsForRepurchaseOfCommonShares": 0, "cf1.PaymentsOfDividends": 0, "cf1.IncreaseDecreaseDeferredContingentConsideration": 0, "cf1.ProceedsFromIssuanceOfLongTermDebt": 0, "cf1.RepaymentsOfLongTermDebt": -13403000, "cf1.FinancingCosts": 0, "cf1.NetChangeInShortTermBorrowings": 0, "cf1.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf1.NetChangeInNonControllingInterests": 0, "cf1.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf1.RepaymentsOfConvertible": 0, "cf1.IssuanceOfConvertible": 0, "cf1.EquityInvesteeAdvancesRepayments": 0, "cf1.OtherFinancingActivities": 508400000, "cf1.CashPaidForTaxes": 0, "cf1.CashPaidForInterest": 0, "cf2.AccessionNumber": "0001178670-20-000004", "cf2.AmendmentFlag": "", "cf2.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "cf2.Period": "secondlastyear", "cf2.PeriodEndDate": "2019-12-31", "cf2.TradingSymbol": "ALNY", "cf2.CashBeginningBalance": 422631000, "cf2.EffectOfExchangeRateOnCash": -83000, "cf2.DepreciationDepletionAndAmortization": 54368000, "cf2.GainRelatedToDisposalOrSale": -11288000, "cf2.RestructuringAndOtherSpecialCharges": 0, "cf2.AccruedEmployeeCompensation": 0, "cf2.ShareBasedCompensation": 174841000, "cf2.IncreaseDecreaseInIncomeTaxExpenseBenefit": 0, "cf2.OtherNonCashIncomeExpense": 0, "cf2.IncreaseDecreaseInAccountsReceivable": -24238000, "cf2.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": -22042000, "cf2.IncreaseDecreaseInInventories": -32411000, "cf2.IncreaseDecreaseInOtherReceivables": 0, "cf2.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 92354000, "cf2.IncreaseDecreaseInContractWithCustomerLiability": 392251000, "cf2.IncreaseDecreaseInRetirementBenefits": 0, "cf2.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf2.IncreaseDecreaseOperatingLeaseCurrent": -33703000, "cf2.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf2.IncreaseDecreaseInOtherOperatingActivities": 17557000, "cf2.PaymentsToAcquireInvestments": -2075925000, "cf2.ProceedsOfInvestments": 1805404000, "cf2.PaymentsToAcquirePropertyPlantAndEquipment": -140156000, "cf2.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf2.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf2.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf2.ProceedsRelatedToInsuranceSettlement": 0, "cf2.ReveiptOfGovernmentGrants": 0, "cf2.PaymentOfLicenseFee": 0, "cf2.InvestingActivitiesInDiscontinuedOperations": 0, "cf2.OtherInvestingActivities": -7000000, "cf2.FinanceLeasePrincipalPayments": 0, "cf2.ProceedsFromIssuanceOfCommonShares": 0, "cf2.ProceedsFromSharePurchasePlanAndOptionsExercice": 71284000, "cf2.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf2.PaymentsForRepurchaseOfCommonShares": 0, "cf2.PaymentsOfDividends": 0, "cf2.IncreaseDecreaseDeferredContingentConsideration": 0, "cf2.ProceedsFromIssuanceOfLongTermDebt": 0, "cf2.RepaymentsOfLongTermDebt": -30000000, "cf2.FinancingCosts": 0, "cf2.NetChangeInShortTermBorrowings": 0, "cf2.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf2.NetChangeInNonControllingInterests": 0, "cf2.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf2.RepaymentsOfConvertible": 0, "cf2.IssuanceOfConvertible": 0, "cf2.EquityInvesteeAdvancesRepayments": 0, "cf2.OtherFinancingActivities": 781900000, "cf2.CashPaidForTaxes": 0, "cf2.CashPaidForInterest": 0, "cf3.AccessionNumber": "0001564590-19-003022", "cf3.AmendmentFlag": "", "cf3.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "cf3.Period": "thirdlastyear", "cf3.PeriodEndDate": "2018-12-31", "cf3.TradingSymbol": "ALNY", "cf3.CashBeginningBalance": 646832000, "cf3.EffectOfExchangeRateOnCash": 0, "cf3.DepreciationDepletionAndAmortization": 6435000, "cf3.GainRelatedToDisposalOrSale": -3564000, "cf3.RestructuringAndOtherSpecialCharges": -10000000, "cf3.AccruedEmployeeCompensation": 0, "cf3.ShareBasedCompensation": 157752000, "cf3.IncreaseDecreaseInIncomeTaxExpenseBenefit": 0, "cf3.OtherNonCashIncomeExpense": 0, "cf3.IncreaseDecreaseInAccountsReceivable": 15242000, "cf3.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": -35067000, "cf3.IncreaseDecreaseInInventories": -22645000, "cf3.IncreaseDecreaseInOtherReceivables": 0, "cf3.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 74835000, "cf3.IncreaseDecreaseInContractWithCustomerLiability": -12616000, "cf3.IncreaseDecreaseInRetirementBenefits": 0, "cf3.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf3.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf3.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf3.IncreaseDecreaseInOtherOperatingActivities": -732988000, "cf3.PaymentsToAcquireInvestments": -1118871000, "cf3.ProceedsOfInvestments": 1518703000, "cf3.PaymentsToAcquirePropertyPlantAndEquipment": -126887000, "cf3.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf3.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf3.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf3.ProceedsRelatedToInsuranceSettlement": 0, "cf3.ReveiptOfGovernmentGrants": 0, "cf3.PaymentOfLicenseFee": 0, "cf3.InvestingActivitiesInDiscontinuedOperations": 0, "cf3.OtherInvestingActivities": 0, "cf3.FinanceLeasePrincipalPayments": 0, "cf3.ProceedsFromIssuanceOfCommonShares": 0, "cf3.ProceedsFromSharePurchasePlanAndOptionsExercice": 68939000, "cf3.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf3.PaymentsForRepurchaseOfCommonShares": -3469000, "cf3.PaymentsOfDividends": 0, "cf3.IncreaseDecreaseDeferredContingentConsideration": 0, "cf3.ProceedsFromIssuanceOfLongTermDebt": 0, "cf3.RepaymentsOfLongTermDebt": 0, "cf3.FinancingCosts": 0, "cf3.NetChangeInShortTermBorrowings": 0, "cf3.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf3.NetChangeInNonControllingInterests": 0, "cf3.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf3.RepaymentsOfConvertible": 0, "cf3.IssuanceOfConvertible": 0, "cf3.EquityInvesteeAdvancesRepayments": 0, "cf3.OtherFinancingActivities": 0, "cf3.CashPaidForTaxes": 0, "cf3.CashPaidForInterest": 0, "cf4.AccessionNumber": "0001564590-18-002152", "cf4.AmendmentFlag": "", "cf4.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "cf4.Period": "fourthlastyear", "cf4.PeriodEndDate": "2017-12-31", "cf4.TradingSymbol": "ALNY", "cf4.CashBeginningBalance": 193617000, "cf4.EffectOfExchangeRateOnCash": 0, "cf4.DepreciationDepletionAndAmortization": 13367000, "cf4.GainRelatedToDisposalOrSale": 1894000, "cf4.RestructuringAndOtherSpecialCharges": 0, "cf4.AccruedEmployeeCompensation": 0, "cf4.ShareBasedCompensation": 92819000, "cf4.IncreaseDecreaseInIncomeTaxExpenseBenefit": 0, "cf4.OtherNonCashIncomeExpense": 0, "cf4.IncreaseDecreaseInAccountsReceivable": -10668000, "cf4.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": -20711000, "cf4.IncreaseDecreaseInInventories": 0, "cf4.IncreaseDecreaseInOtherReceivables": 0, "cf4.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 26629000, "cf4.IncreaseDecreaseInContractWithCustomerLiability": 1848000, "cf4.IncreaseDecreaseInRetirementBenefits": 0, "cf4.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf4.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf4.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf4.IncreaseDecreaseInOtherOperatingActivities": -487964000, "cf4.PaymentsToAcquireInvestments": -903457000, "cf4.ProceedsOfInvestments": 717305000, "cf4.PaymentsToAcquirePropertyPlantAndEquipment": -104209000, "cf4.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf4.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf4.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf4.ProceedsRelatedToInsuranceSettlement": 0, "cf4.ReveiptOfGovernmentGrants": 0, "cf4.PaymentOfLicenseFee": 0, "cf4.InvestingActivitiesInDiscontinuedOperations": 0, "cf4.OtherInvestingActivities": 0, "cf4.FinanceLeasePrincipalPayments": 0, "cf4.ProceedsFromIssuanceOfCommonShares": 1161006000, "cf4.ProceedsFromSharePurchasePlanAndOptionsExercice": 84142000, "cf4.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf4.PaymentsForRepurchaseOfCommonShares": -257000, "cf4.PaymentsOfDividends": 0, "cf4.IncreaseDecreaseDeferredContingentConsideration": 0, "cf4.ProceedsFromIssuanceOfLongTermDebt": 0, "cf4.RepaymentsOfLongTermDebt": -120000000, "cf4.FinancingCosts": 0, "cf4.NetChangeInShortTermBorrowings": 0, "cf4.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf4.NetChangeInNonControllingInterests": 0, "cf4.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf4.RepaymentsOfConvertible": 0, "cf4.IssuanceOfConvertible": 0, "cf4.EquityInvesteeAdvancesRepayments": 0, "cf4.OtherFinancingActivities": 0, "cf4.CashPaidForTaxes": 0, "cf4.CashPaidForInterest": 0, "cf5.AccessionNumber": "0001564590-17-001649", "cf5.AmendmentFlag": "", "cf5.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "cf5.Period": "fifthlastyear", "cf5.PeriodEndDate": "2016-12-31", "cf5.TradingSymbol": "ALNY", "cf5.CashBeginningBalance": 180895000, "cf5.EffectOfExchangeRateOnCash": 0, "cf5.DepreciationDepletionAndAmortization": 15130000, "cf5.GainRelatedToDisposalOrSale": -6977000, "cf5.RestructuringAndOtherSpecialCharges": 0, "cf5.AccruedEmployeeCompensation": 0, "cf5.ShareBasedCompensation": 75528000, "cf5.IncreaseDecreaseInIncomeTaxExpenseBenefit": 0, "cf5.OtherNonCashIncomeExpense": 0, "cf5.IncreaseDecreaseInAccountsReceivable": -15036000, "cf5.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": -5276000, "cf5.IncreaseDecreaseInInventories": 0, "cf5.IncreaseDecreaseInOtherReceivables": 0, "cf5.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 20771000, "cf5.IncreaseDecreaseInContractWithCustomerLiability": 14615000, "cf5.IncreaseDecreaseInRetirementBenefits": 0, "cf5.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf5.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf5.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf5.IncreaseDecreaseInOtherOperatingActivities": -406456000, "cf5.PaymentsToAcquireInvestments": -909310000, "cf5.ProceedsOfInvestments": 1116458000, "cf5.PaymentsToAcquirePropertyPlantAndEquipment": -64557000, "cf5.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf5.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf5.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf5.ProceedsRelatedToInsuranceSettlement": 0, "cf5.ReveiptOfGovernmentGrants": 0, "cf5.PaymentOfLicenseFee": 0, "cf5.InvestingActivitiesInDiscontinuedOperations": 0, "cf5.OtherInvestingActivities": 0, "cf5.FinanceLeasePrincipalPayments": 0, "cf5.ProceedsFromIssuanceOfCommonShares": 14301000, "cf5.ProceedsFromSharePurchasePlanAndOptionsExercice": 14127000, "cf5.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf5.PaymentsForRepurchaseOfCommonShares": -596000, "cf5.PaymentsOfDividends": 0, "cf5.IncreaseDecreaseDeferredContingentConsideration": 0, "cf5.ProceedsFromIssuanceOfLongTermDebt": 150000000, "cf5.RepaymentsOfLongTermDebt": 0, "cf5.FinancingCosts": 0, "cf5.NetChangeInShortTermBorrowings": 0, "cf5.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf5.NetChangeInNonControllingInterests": 0, "cf5.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf5.RepaymentsOfConvertible": 0, "cf5.IssuanceOfConvertible": 0, "cf5.EquityInvesteeAdvancesRepayments": 0, "cf5.OtherFinancingActivities": 0, "cf5.CashPaidForTaxes": 0, "cf5.CashPaidForInterest": 0, "cf6.AccessionNumber": "0001193125-16-462538", "cf6.AmendmentFlag": "", "cf6.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "cf6.Period": "sixthlastyear", "cf6.PeriodEndDate": "2015-12-31", "cf6.TradingSymbol": "ALNY", "cf6.CashBeginningBalance": 75179000, "cf6.EffectOfExchangeRateOnCash": 0, "cf6.DepreciationDepletionAndAmortization": 19050000, "cf6.GainRelatedToDisposalOrSale": 0, "cf6.RestructuringAndOtherSpecialCharges": 0, "cf6.AccruedEmployeeCompensation": 0, "cf6.ShareBasedCompensation": 45783000, "cf6.IncreaseDecreaseInIncomeTaxExpenseBenefit": 0, "cf6.OtherNonCashIncomeExpense": 0, "cf6.IncreaseDecreaseInAccountsReceivable": 31639000, "cf6.IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": -6820000, "cf6.IncreaseDecreaseInInventories": 0, "cf6.IncreaseDecreaseInOtherReceivables": 0, "cf6.IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": 8019000, "cf6.IncreaseDecreaseInContractWithCustomerLiability": 1904000, "cf6.IncreaseDecreaseInRetirementBenefits": 0, "cf6.IncreaseDecreaseFinanceLeaseCurrent": 0, "cf6.IncreaseDecreaseOperatingLeaseCurrent": 0, "cf6.IncreaseDecreaseInFairValueOfDerivativesOperating": 0, "cf6.IncreaseDecreaseInOtherOperatingActivities": -288715000, "cf6.PaymentsToAcquireInvestments": -1033843000, "cf6.ProceedsOfInvestments": 726943000, "cf6.PaymentsToAcquirePropertyPlantAndEquipment": -12950000, "cf6.ProceedsFromDisposalsOfPropertyAndEquipment": 0, "cf6.PaymentsToAcquireBusinessesAndIntangibles": 0, "cf6.ProceedsFromDisposalsOfBusinessesAndIntangibles": 0, "cf6.ProceedsRelatedToInsuranceSettlement": 0, "cf6.ReveiptOfGovernmentGrants": 0, "cf6.PaymentOfLicenseFee": 0, "cf6.InvestingActivitiesInDiscontinuedOperations": 0, "cf6.OtherInvestingActivities": -1471000, "cf6.FinanceLeasePrincipalPayments": 0, "cf6.ProceedsFromIssuanceOfCommonShares": 585418000, "cf6.ProceedsFromSharePurchasePlanAndOptionsExercice": 31137000, "cf6.PaymentsRelatedToTaxWithholdingForShareBasedCompensation": 0, "cf6.PaymentsForRepurchaseOfCommonShares": -378000, "cf6.PaymentsOfDividends": 0, "cf6.IncreaseDecreaseDeferredContingentConsideration": 0, "cf6.ProceedsFromIssuanceOfLongTermDebt": 0, "cf6.RepaymentsOfLongTermDebt": 0, "cf6.FinancingCosts": 0, "cf6.NetChangeInShortTermBorrowings": 0, "cf6.NetChangeInForwardAndHedgesClassifiedAsFinancingActivities": 0, "cf6.NetChangeInNonControllingInterests": 0, "cf6.ProceedsFromRepaymentsOfCommercialPaper": 0, "cf6.RepaymentsOfConvertible": 0, "cf6.IssuanceOfConvertible": 0, "cf6.EquityInvesteeAdvancesRepayments": 0, "cf6.OtherFinancingActivities": 0, "cf6.CashPaidForTaxes": 0, "cf6.CashPaidForInterest": 0, "tb1.AccessionNumber": "0001178670-21-000010", "tb1.AmendmentFlag": "", "tb1.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "tb1.Link": "0", "tb1.Period": "lastyear", "tb1.PeriodEndDate": "2020-12-31", "tb1.PeriodOfReport": "0", "tb1.TradingSymbol": "ALNY", "tb1.Cash": 496580000, "tb1.ShortTermInvestments": 1377815000, "tb1.AccountsReceivable": 602413000, "tb1.WorkInProgress": 0, "tb1.Inventories": 75202000, "tb1.PrepaidExpenses": 62767000, "tb1.NonTradeReceivables": 0, "tb1.PrepaidTaxAssetsCurrent": 0, "tb1.DeferredTaxAssetsCurrent": 0, "tb1.RightOfUseAssetsCurrent": 0, "tb1.OtherCurrentAssets": 0, "tb1.DiscontinuedOperationsCurrent": 0, "tb1.LongTermReceivables": 0, "tb1.DeferredCharges": 0, "tb1.Investments": 40725000, "tb1.PropertyPlantAndEquipment": 465029000, "tb1.OperatingLeaseRightOfUseAssets": 241485000, "tb1.FinanceLeaseRightOfUseAssets": 0, "tb1.IntangibleAssets": 0, "tb1.Goodwill": 0, "tb1.RefundableTaxAssetsNonCurrent": 0, "tb1.DeferredTaxAssetsNonCurrent": 0, "tb1.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb1.OtherNonCurrentAssets": 45045000, "tb1.DiscontinuedOperations": 0, "tb1.AccountsPayableAndAccruedLiabilities": -407875000, "tb1.EmployeeCompensationCurrent": 0, "tb1.OperatingLeasesCurrent": -36872000, "tb1.FinanceLeasesCurrent": 0, "tb1.DeferredRevenueAndDepositsCurrent": -127207000, "tb1.AccruedTaxLiabilities": 0, "tb1.DeferredTaxLiabilitiesCurrent": 0, "tb1.CommercialPapers": 0, "tb1.ShortTermBorrowings": 0, "tb1.OtherCurrentLiabilities": -13316000, "tb1.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb1.DividendsPayable": 0, "tb1.ShortTermPortionOfLongTermDebt": 0, "tb1.LongTermDebt": -191278000, "tb1.PreferredSharesLiability": 0, "tb1.RetirementBenefits": 0, "tb1.OperatingLeasesNonCurrent": -293039000, "tb1.FinanceLeasesNonCurrent": 0, "tb1.LeaseIncentiveObligation": 0, "tb1.DeferredRevenueAndDepositsNonCurrent": -225094000, "tb1.ContingentConsideration": 0, "tb1.AccruedTaxLiabilitiesNonCurrent": 0, "tb1.DeferredTaxLiabilitiesNonCurrent": 0, "tb1.OtherNonCurrentLiabilities": -1109449000, "tb1.RedeemableNonControllingInterests": 0, "tb1.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb1.ConvertibleDebtBeginning": 0, "tb1.CommonSharesBeginning": -5202298000, "tb1.CommonSharesIssued": -883058000, "tb1.ShareBasedCompensation": 440118000, "tb1.PreferredSharesBeginning": 0, "tb1.RetainedEarningsBeginning": 3727088000, "tb1.DividendsAndDividendEquivalentsDeclared": 0, "tb1.CommonSharesRepurchasedAndRetired": 0, "tb1.ShareBasedCompensationRetainedEarnings": 0, "tb1.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb1.RetainedEarningsOthers": 0, "tb1.AccumulatedOtherComprehensiveIncomeBeginning": 36518000, "tb1.TreasurySharesBeginning": 0, "tb1.PurchaseAndSellOfTreasuryShares": 0, "tb1.EmployeeBenefitTrustBeginning": 0, "tb1.NonControllingInterestsBeginning": 0, "tb1.DividendsDeclaredToNonControllingInterests": 0, "tb1.AcquisitionOfNonControllingInterests": 0, "tb1.NonControllingInterestsOthers": 0, "tb1.Sales": -361520000, "tb1.CostOfSales": 78052000, "tb1.ResearchAndDevelopment": 654819000, "tb1.SellingGeneralAdministrativeAndMarketing": 457087000, "tb1.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb1.NonOperatingIncome": 27162000, "tb1.IncomeTaxExpenseBenefit": 2681000, "tb1.EquityMethodInvesteesIncome": 0, "tb1.NetIncomeFromDiscontinuedOperations": 0, "tb1.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb1.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb1.ChangeInUnrealizedGainsLossesOnInvestments": 7104000, "tb1.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb1.IncomeTaxOnOtherComprehensiveIncome": 0, "tb2.AccessionNumber": "0001178670-20-000004", "tb2.AmendmentFlag": "", "tb2.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "tb2.Link": "0", "tb2.Period": "secondlastyear", "tb2.PeriodEndDate": "2019-12-31", "tb2.PeriodOfReport": "0", "tb2.TradingSymbol": "ALNY", "tb2.Cash": 547178000, "tb2.ShortTermInvestments": 988984000, "tb2.AccountsReceivable": 43011000, "tb2.WorkInProgress": 0, "tb2.Inventories": 56348000, "tb2.PrepaidExpenses": 80343000, "tb2.NonTradeReceivables": 0, "tb2.PrepaidTaxAssetsCurrent": 0, "tb2.DeferredTaxAssetsCurrent": 0, "tb2.RightOfUseAssetsCurrent": 0, "tb2.OtherCurrentAssets": 0, "tb2.DiscontinuedOperationsCurrent": 0, "tb2.LongTermReceivables": 0, "tb2.DeferredCharges": 0, "tb2.Investments": 14825000, "tb2.PropertyPlantAndEquipment": 425179000, "tb2.OperatingLeaseRightOfUseAssets": 221197000, "tb2.FinanceLeaseRightOfUseAssets": 0, "tb2.IntangibleAssets": 0, "tb2.Goodwill": 0, "tb2.RefundableTaxAssetsNonCurrent": 0, "tb2.DeferredTaxAssetsNonCurrent": 0, "tb2.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb2.OtherNonCurrentAssets": 18069000, "tb2.DiscontinuedOperations": 0, "tb2.AccountsPayableAndAccruedLiabilities": -247085000, "tb2.EmployeeCompensationCurrent": 0, "tb2.OperatingLeasesCurrent": -27688000, "tb2.FinanceLeasesCurrent": 0, "tb2.DeferredRevenueAndDepositsCurrent": -77821000, "tb2.AccruedTaxLiabilities": 0, "tb2.DeferredTaxLiabilitiesCurrent": 0, "tb2.CommercialPapers": 0, "tb2.ShortTermBorrowings": 0, "tb2.OtherCurrentLiabilities": 0, "tb2.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb2.DividendsPayable": 0, "tb2.ShortTermPortionOfLongTermDebt": 0, "tb2.LongTermDebt": 0, "tb2.PreferredSharesLiability": 0, "tb2.RetirementBenefits": 0, "tb2.OperatingLeasesNonCurrent": -276135000, "tb2.FinanceLeasesNonCurrent": 0, "tb2.LeaseIncentiveObligation": 0, "tb2.DeferredRevenueAndDepositsNonCurrent": -318383000, "tb2.ContingentConsideration": 0, "tb2.AccruedTaxLiabilitiesNonCurrent": 0, "tb2.DeferredTaxLiabilitiesNonCurrent": 0, "tb2.OtherNonCurrentLiabilities": -9330000, "tb2.RedeemableNonControllingInterests": 0, "tb2.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb2.ConvertibleDebtBeginning": 0, "tb2.CommonSharesBeginning": -4176150000, "tb2.CommonSharesIssued": -785419000, "tb2.ShareBasedCompensation": -240729000, "tb2.PreferredSharesBeginning": 0, "tb2.RetainedEarningsBeginning": 2840972000, "tb2.DividendsAndDividendEquivalentsDeclared": 0, "tb2.CommonSharesRepurchasedAndRetired": 0, "tb2.ShareBasedCompensationRetainedEarnings": 0, "tb2.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb2.RetainedEarningsOthers": 0, "tb2.AccumulatedOtherComprehensiveIncomeBeginning": 33213000, "tb2.TreasurySharesBeginning": 0, "tb2.PurchaseAndSellOfTreasuryShares": 0, "tb2.EmployeeBenefitTrustBeginning": 0, "tb2.NonControllingInterestsBeginning": 0, "tb2.DividendsDeclaredToNonControllingInterests": 0, "tb2.AcquisitionOfNonControllingInterests": 0, "tb2.NonControllingInterestsOthers": 0, "tb2.Sales": -166537000, "tb2.CostOfSales": 25062000, "tb2.ResearchAndDevelopment": 655114000, "tb2.SellingGeneralAdministrativeAndMarketing": 425792000, "tb2.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb2.NonOperatingIncome": -54178000, "tb2.IncomeTaxExpenseBenefit": 863000, "tb2.EquityMethodInvesteesIncome": 0, "tb2.NetIncomeFromDiscontinuedOperations": 0, "tb2.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb2.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb2.ChangeInUnrealizedGainsLossesOnInvestments": 3305000, "tb2.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb2.IncomeTaxOnOtherComprehensiveIncome": 0, "tb3.AccessionNumber": "0001564590-19-003022", "tb3.AmendmentFlag": "", "tb3.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "tb3.Link": "0", "tb3.Period": "thirdlastyear", "tb3.PeriodEndDate": "2018-12-31", "tb3.PeriodOfReport": "0", "tb3.TradingSymbol": "ALNY", "tb3.Cash": 420146000, "tb3.ShortTermInvestments": 664009000, "tb3.AccountsReceivable": 18760000, "tb3.WorkInProgress": 0, "tb3.Inventories": 24068000, "tb3.PrepaidExpenses": 73713000, "tb3.NonTradeReceivables": 0, "tb3.PrepaidTaxAssetsCurrent": 0, "tb3.DeferredTaxAssetsCurrent": 0, "tb3.RightOfUseAssetsCurrent": 0, "tb3.OtherCurrentAssets": 0, "tb3.DiscontinuedOperationsCurrent": 0, "tb3.LongTermReceivables": 0, "tb3.DeferredCharges": 0, "tb3.Investments": 44825000, "tb3.PropertyPlantAndEquipment": 320658000, "tb3.OperatingLeaseRightOfUseAssets": 0, "tb3.FinanceLeaseRightOfUseAssets": 0, "tb3.IntangibleAssets": 0, "tb3.Goodwill": 0, "tb3.RefundableTaxAssetsNonCurrent": 0, "tb3.DeferredTaxAssetsNonCurrent": 0, "tb3.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb3.OtherNonCurrentAssets": 8623000, "tb3.DiscontinuedOperations": 0, "tb3.AccountsPayableAndAccruedLiabilities": -172427000, "tb3.EmployeeCompensationCurrent": 0, "tb3.OperatingLeasesCurrent": 0, "tb3.FinanceLeasesCurrent": 0, "tb3.DeferredRevenueAndDepositsCurrent": -3496000, "tb3.AccruedTaxLiabilities": 0, "tb3.DeferredTaxLiabilitiesCurrent": -3571000, "tb3.CommercialPapers": 0, "tb3.ShortTermBorrowings": 0, "tb3.OtherCurrentLiabilities": 0, "tb3.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb3.DividendsPayable": 0, "tb3.ShortTermPortionOfLongTermDebt": 0, "tb3.LongTermDebt": -30000000, "tb3.PreferredSharesLiability": 0, "tb3.RetirementBenefits": 0, "tb3.OperatingLeasesNonCurrent": 0, "tb3.FinanceLeasesNonCurrent": 0, "tb3.LeaseIncentiveObligation": 0, "tb3.DeferredRevenueAndDepositsNonCurrent": -458000, "tb3.ContingentConsideration": 0, "tb3.AccruedTaxLiabilitiesNonCurrent": 0, "tb3.DeferredTaxLiabilitiesNonCurrent": 0, "tb3.OtherNonCurrentLiabilities": -62885000, "tb3.RedeemableNonControllingInterests": 0, "tb3.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb3.ConvertibleDebtBeginning": 0, "tb3.CommonSharesBeginning": -3948549000, "tb3.CommonSharesIssued": 0, "tb3.ShareBasedCompensation": -227601000, "tb3.PreferredSharesBeginning": 0, "tb3.RetainedEarningsBeginning": 2147685000, "tb3.DividendsAndDividendEquivalentsDeclared": 0, "tb3.CommonSharesRepurchasedAndRetired": 0, "tb3.ShareBasedCompensationRetainedEarnings": 0, "tb3.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb3.RetainedEarningsOthers": 693287000, "tb3.AccumulatedOtherComprehensiveIncomeBeginning": 34433000, "tb3.TreasurySharesBeginning": 0, "tb3.PurchaseAndSellOfTreasuryShares": 0, "tb3.EmployeeBenefitTrustBeginning": 0, "tb3.NonControllingInterestsBeginning": 0, "tb3.DividendsDeclaredToNonControllingInterests": 0, "tb3.AcquisitionOfNonControllingInterests": 0, "tb3.NonControllingInterestsOthers": 0, "tb3.Sales": 0, "tb3.CostOfSales": 0, "tb3.ResearchAndDevelopment": 0, "tb3.SellingGeneralAdministrativeAndMarketing": 0, "tb3.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb3.NonOperatingIncome": 0, "tb3.IncomeTaxExpenseBenefit": 0, "tb3.EquityMethodInvesteesIncome": 0, "tb3.NetIncomeFromDiscontinuedOperations": 0, "tb3.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb3.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb3.ChangeInUnrealizedGainsLossesOnInvestments": -2043000, "tb3.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb3.IncomeTaxOnOtherComprehensiveIncome": 823000, "tb4.AccessionNumber": "0001564590-18-002152", "tb4.AmendmentFlag": "", "tb4.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "tb4.Link": "0", "tb4.Period": "fourthlastyear", "tb4.PeriodEndDate": "2017-12-31", "tb4.PeriodOfReport": "0", "tb4.TradingSymbol": "ALNY", "tb4.Cash": 645361000, "tb4.ShortTermInvestments": 1045257000, "tb4.AccountsReceivable": 34002000, "tb4.WorkInProgress": 0, "tb4.Inventories": 0, "tb4.PrepaidExpenses": 40120000, "tb4.NonTradeReceivables": 0, "tb4.PrepaidTaxAssetsCurrent": 0, "tb4.DeferredTaxAssetsCurrent": 0, "tb4.RightOfUseAssetsCurrent": 0, "tb4.OtherCurrentAssets": 0, "tb4.DiscontinuedOperationsCurrent": 0, "tb4.LongTermReceivables": 0, "tb4.DeferredCharges": 0, "tb4.Investments": 43919000, "tb4.PropertyPlantAndEquipment": 181900000, "tb4.OperatingLeaseRightOfUseAssets": 0, "tb4.FinanceLeaseRightOfUseAssets": 0, "tb4.IntangibleAssets": 0, "tb4.Goodwill": 0, "tb4.RefundableTaxAssetsNonCurrent": 0, "tb4.DeferredTaxAssetsNonCurrent": 0, "tb4.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb4.OtherNonCurrentAssets": 4171000, "tb4.DiscontinuedOperations": 0, "tb4.AccountsPayableAndAccruedLiabilities": -100558000, "tb4.EmployeeCompensationCurrent": 0, "tb4.OperatingLeasesCurrent": 0, "tb4.FinanceLeasesCurrent": 0, "tb4.DeferredRevenueAndDepositsCurrent": -41705000, "tb4.AccruedTaxLiabilities": 0, "tb4.DeferredTaxLiabilitiesCurrent": -1988000, "tb4.CommercialPapers": 0, "tb4.ShortTermBorrowings": 0, "tb4.OtherCurrentLiabilities": 0, "tb4.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb4.DividendsPayable": 0, "tb4.ShortTermPortionOfLongTermDebt": 0, "tb4.LongTermDebt": -30000000, "tb4.PreferredSharesLiability": 0, "tb4.RetirementBenefits": 0, "tb4.OperatingLeasesNonCurrent": 0, "tb4.FinanceLeasesNonCurrent": 0, "tb4.LeaseIncentiveObligation": 0, "tb4.DeferredRevenueAndDepositsNonCurrent": -43075000, "tb4.ContingentConsideration": 0, "tb4.AccruedTaxLiabilitiesNonCurrent": 0, "tb4.DeferredTaxLiabilitiesNonCurrent": 0, "tb4.OtherNonCurrentLiabilities": -10973000, "tb4.RedeemableNonControllingInterests": 0, "tb4.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb4.ConvertibleDebtBeginning": 0, "tb4.CommonSharesBeginning": -2610473000, "tb4.CommonSharesIssued": 0, "tb4.ShareBasedCompensation": -1338076000, "tb4.PreferredSharesBeginning": 0, "tb4.RetainedEarningsBeginning": 1656811000, "tb4.DividendsAndDividendEquivalentsDeclared": 0, "tb4.CommonSharesRepurchasedAndRetired": 0, "tb4.ShareBasedCompensationRetainedEarnings": 0, "tb4.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb4.RetainedEarningsOthers": 490874000, "tb4.AccumulatedOtherComprehensiveIncomeBeginning": 33441000, "tb4.TreasurySharesBeginning": 0, "tb4.PurchaseAndSellOfTreasuryShares": 0, "tb4.EmployeeBenefitTrustBeginning": 0, "tb4.NonControllingInterestsBeginning": 0, "tb4.DividendsDeclaredToNonControllingInterests": 0, "tb4.AcquisitionOfNonControllingInterests": 0, "tb4.NonControllingInterestsOthers": 0, "tb4.Sales": 0, "tb4.CostOfSales": 0, "tb4.ResearchAndDevelopment": 0, "tb4.SellingGeneralAdministrativeAndMarketing": 0, "tb4.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb4.NonOperatingIncome": 0, "tb4.IncomeTaxExpenseBenefit": 0, "tb4.EquityMethodInvesteesIncome": 0, "tb4.NetIncomeFromDiscontinuedOperations": 0, "tb4.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb4.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb4.ChangeInUnrealizedGainsLossesOnInvestments": 992000, "tb4.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb4.IncomeTaxOnOtherComprehensiveIncome": 0, "tb5.AccessionNumber": "0001564590-17-001649", "tb5.AmendmentFlag": "", "tb5.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "tb5.Link": "0", "tb5.Period": "fifthlastyear", "tb5.PeriodEndDate": "2016-12-31", "tb5.PeriodOfReport": "0", "tb5.TradingSymbol": "ALNY", "tb5.Cash": 193617000, "tb5.ShortTermInvestments": 433182000, "tb5.AccountsReceivable": 23334000, "tb5.WorkInProgress": 0, "tb5.Inventories": 0, "tb5.PrepaidExpenses": 21744000, "tb5.NonTradeReceivables": 0, "tb5.PrepaidTaxAssetsCurrent": 0, "tb5.DeferredTaxAssetsCurrent": 0, "tb5.RightOfUseAssetsCurrent": 0, "tb5.OtherCurrentAssets": 0, "tb5.DiscontinuedOperationsCurrent": 0, "tb5.LongTermReceivables": 0, "tb5.DeferredCharges": 0, "tb5.Investments": 474799000, "tb5.PropertyPlantAndEquipment": 114572000, "tb5.OperatingLeaseRightOfUseAssets": 0, "tb5.FinanceLeaseRightOfUseAssets": 0, "tb5.IntangibleAssets": 0, "tb5.Goodwill": 0, "tb5.RefundableTaxAssetsNonCurrent": 0, "tb5.DeferredTaxAssetsNonCurrent": 0, "tb5.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb5.OtherNonCurrentAssets": 1562000, "tb5.DiscontinuedOperations": 0, "tb5.AccountsPayableAndAccruedLiabilities": -96583000, "tb5.EmployeeCompensationCurrent": 0, "tb5.OperatingLeasesCurrent": 0, "tb5.FinanceLeasesCurrent": 0, "tb5.DeferredRevenueAndDepositsCurrent": -33540000, "tb5.AccruedTaxLiabilities": 0, "tb5.DeferredTaxLiabilitiesCurrent": -1576000, "tb5.CommercialPapers": 0, "tb5.ShortTermBorrowings": 0, "tb5.OtherCurrentLiabilities": 0, "tb5.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb5.DividendsPayable": 0, "tb5.ShortTermPortionOfLongTermDebt": 0, "tb5.LongTermDebt": -150000000, "tb5.PreferredSharesLiability": 0, "tb5.RetirementBenefits": 0, "tb5.OperatingLeasesNonCurrent": 0, "tb5.FinanceLeasesNonCurrent": 0, "tb5.LeaseIncentiveObligation": 0, "tb5.DeferredRevenueAndDepositsNonCurrent": -49392000, "tb5.ContingentConsideration": 0, "tb5.AccruedTaxLiabilitiesNonCurrent": 0, "tb5.DeferredTaxLiabilitiesNonCurrent": 0, "tb5.OtherNonCurrentLiabilities": -11498000, "tb5.RedeemableNonControllingInterests": 0, "tb5.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb5.ConvertibleDebtBeginning": 0, "tb5.CommonSharesBeginning": -2507048000, "tb5.CommonSharesIssued": 0, "tb5.ShareBasedCompensation": -103425000, "tb5.PreferredSharesBeginning": 0, "tb5.RetainedEarningsBeginning": 1246703000, "tb5.DividendsAndDividendEquivalentsDeclared": 0, "tb5.CommonSharesRepurchasedAndRetired": 0, "tb5.ShareBasedCompensationRetainedEarnings": 0, "tb5.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb5.RetainedEarningsOthers": 410108000, "tb5.AccumulatedOtherComprehensiveIncomeBeginning": -4369000, "tb5.TreasurySharesBeginning": 0, "tb5.PurchaseAndSellOfTreasuryShares": 0, "tb5.EmployeeBenefitTrustBeginning": 0, "tb5.NonControllingInterestsBeginning": 0, "tb5.DividendsDeclaredToNonControllingInterests": 0, "tb5.AcquisitionOfNonControllingInterests": 0, "tb5.NonControllingInterestsOthers": 0, "tb5.Sales": 0, "tb5.CostOfSales": 0, "tb5.ResearchAndDevelopment": 0, "tb5.SellingGeneralAdministrativeAndMarketing": 0, "tb5.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb5.NonOperatingIncome": 0, "tb5.IncomeTaxExpenseBenefit": 0, "tb5.EquityMethodInvesteesIncome": 0, "tb5.NetIncomeFromDiscontinuedOperations": 0, "tb5.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb5.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb5.ChangeInUnrealizedGainsLossesOnInvestments": 37810000, "tb5.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb5.IncomeTaxOnOtherComprehensiveIncome": 0, "tb6.AccessionNumber": "0001193125-16-462538", "tb6.AmendmentFlag": "", "tb6.EntityRegistrantName": "ALNYLAM PHARMACEUTICALS, INC.", "tb6.Link": "0", "tb6.Period": "sixthlastyear", "tb6.PeriodEndDate": "2015-12-31", "tb6.PeriodOfReport": "0", "tb6.TradingSymbol": "ALNY", "tb6.Cash": 180895000, "tb6.ShortTermInvestments": 899636000, "tb6.AccountsReceivable": 8298000, "tb6.WorkInProgress": 0, "tb6.Inventories": 0, "tb6.PrepaidExpenses": 16559000, "tb6.NonTradeReceivables": 0, "tb6.PrepaidTaxAssetsCurrent": 0, "tb6.DeferredTaxAssetsCurrent": 0, "tb6.RightOfUseAssetsCurrent": 0, "tb6.OtherCurrentAssets": 0, "tb6.DiscontinuedOperationsCurrent": 0, "tb6.LongTermReceivables": 0, "tb6.DeferredCharges": 0, "tb6.Investments": 251839000, "tb6.PropertyPlantAndEquipment": 27812000, "tb6.OperatingLeaseRightOfUseAssets": 0, "tb6.FinanceLeaseRightOfUseAssets": 0, "tb6.IntangibleAssets": 0, "tb6.Goodwill": 0, "tb6.RefundableTaxAssetsNonCurrent": 0, "tb6.DeferredTaxAssetsNonCurrent": 0, "tb6.DefinedBenefitPensionAndOtherSimilarPlans": 0, "tb6.OtherNonCurrentAssets": 1471000, "tb6.DiscontinuedOperations": 0, "tb6.AccountsPayableAndAccruedLiabilities": -45585000, "tb6.EmployeeCompensationCurrent": 0, "tb6.OperatingLeasesCurrent": 0, "tb6.FinanceLeasesCurrent": 0, "tb6.DeferredRevenueAndDepositsCurrent": -15352000, "tb6.AccruedTaxLiabilities": 0, "tb6.DeferredTaxLiabilitiesCurrent": -1162000, "tb6.CommercialPapers": 0, "tb6.ShortTermBorrowings": 0, "tb6.OtherCurrentLiabilities": 0, "tb6.DiscontinuedOperationsLiabilitiesCurrent": 0, "tb6.DividendsPayable": 0, "tb6.ShortTermPortionOfLongTermDebt": 0, "tb6.LongTermDebt": 0, "tb6.PreferredSharesLiability": 0, "tb6.RetirementBenefits": 0, "tb6.OperatingLeasesNonCurrent": 0, "tb6.FinanceLeasesNonCurrent": 0, "tb6.LeaseIncentiveObligation": 0, "tb6.DeferredRevenueAndDepositsNonCurrent": -52965000, "tb6.ContingentConsideration": 0, "tb6.AccruedTaxLiabilitiesNonCurrent": 0, "tb6.DeferredTaxLiabilitiesNonCurrent": 0, "tb6.OtherNonCurrentLiabilities": -6732000, "tb6.RedeemableNonControllingInterests": 0, "tb6.DiscontinuedOperationsLiabilitiesNonCurrent": 0, "tb6.ConvertibleDebtBeginning": 0, "tb6.CommonSharesBeginning": -2507048000, "tb6.CommonSharesIssued": 0, "tb6.ShareBasedCompensation": 0, "tb6.PreferredSharesBeginning": 0, "tb6.RetainedEarningsBeginning": 1246703000, "tb6.DividendsAndDividendEquivalentsDeclared": 0, "tb6.CommonSharesRepurchasedAndRetired": 0, "tb6.ShareBasedCompensationRetainedEarnings": 0, "tb6.EffectOfAdoptionOfNewAccountingPronouncementOrTaxCuts": 0, "tb6.RetainedEarningsOthers": 0, "tb6.AccumulatedOtherComprehensiveIncomeBeginning": -48763000, "tb6.TreasurySharesBeginning": 0, "tb6.PurchaseAndSellOfTreasuryShares": 0, "tb6.EmployeeBenefitTrustBeginning": 0, "tb6.NonControllingInterestsBeginning": 0, "tb6.DividendsDeclaredToNonControllingInterests": 0, "tb6.AcquisitionOfNonControllingInterests": 0, "tb6.NonControllingInterestsOthers": 0, "tb6.Sales": 0, "tb6.CostOfSales": 0, "tb6.ResearchAndDevelopment": 0, "tb6.SellingGeneralAdministrativeAndMarketing": 0, "tb6.ImpairmentRestructuringAndOtherSpecialCharges": 0, "tb6.NonOperatingIncome": 0, "tb6.IncomeTaxExpenseBenefit": 0, "tb6.EquityMethodInvesteesIncome": 0, "tb6.NetIncomeFromDiscontinuedOperations": 0, "tb6.ChangeInForeignCurrencyTranslationAdjustment": 0, "tb6.ChangeInUnrealizedGainsLossesOnDerivativeInstruments": 0, "tb6.ChangeInUnrealizedGainsLossesOnInvestments": 44394000, "tb6.ChangeInDefinedBenefitPensionAndOtherSimilarPlans": 0, "tb6.IncomeTaxOnOtherComprehensiveIncome": 0}]}